A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname
PLOS One · 2026
DOI: 10.1371/journal.pone.0344187 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Roxane Schaub und 21 weiteren Autor:innen. Beteiligte Einrichtung: CIC Inserm 1424, Centre Hospitalier Universitaire de Guyane, Cayenne, French Guiana. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis D, Hepatitis B, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Agence Nationale de Recherches sur le Sida et les Hépatites Virales.
Abstract (Originalsprache)
Background
National epidemiological data are essential to achieve viral hepatitis elimination goals. However, viral hepatitis and HIV epidemiology in French Guiana (FG) and Suriname is mainly limited to urban areas. We therefore assessed the prevalence, associated determinants, and knowledge, attitudes, practices, and beliefs (KAP-B) regarding hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and HIV in the isolated area of the Maroni River, bordering FG and Suriname.
Methods
Between January 2018 and February 2019, adults (≥18 years) living along the Maroni were enrolled in this cross-sectional study and completed a risk factor and KAP-B questionnaire. Participants were tested for viral hepatitis and HIV using serological and molecular analyses: HBV (HBsAg, anti-HBcore antibodies, anti-HBs, HBV DNA), HCV (HCV-antibodies, HCV RNA), HDV (HDV-antibodies), and HIV (HIV-antibodies/antigen, HIV RNA). Age- and sex-adjusted HBV, HCV, and HIV prevalences were estimated using post-stratification weighting.
Findings
Among 2286 participants, adjusted prevalences were respectively 2.08% (95%CI: 1.49–2.66; n = 46) for HBsAg, 25.6%, (95%CI: 20.89–29.24, n = 646) for resolved HBV infection (negative HBsAg and positive anti-HBcore antibodies), 0.13% (95%CI: 0.0–0.27; n = 5) for HCV-antibodies, and 0.65% (95%CI: 0.0–1.40; n = 12) for HIV-antibodies. There were no HDV infections. HBV exposure (acute or resolved) was independently associated with age (per 10-year increase aOR:1.27, 95%CI: 1.18–1.37, p < 0.0001), males (aOR:1.34, 95%CI: 1.10–1.65, p = 0.006), Maroon (aOR:2.22, 95%CI: 1.27–4.06) or other ethnic groups (aOR:2.94, 95%CI: 1.61–5.59) versus Amerindians, (p = 0.002), and higher education (aOR:0.71, 95%CI: 0.56–0.90, p = 0.005). Older age (per 10-years increase aOR:1.64, 95%CI: 1.11–2.44), p = 0.01) and non-autochthonous origin (aOR:3.81, 95%CI: 1.14–12.26, p = 0.02) were associated with HIV. Less than one in six participants correctly identified viral hepatitis transmission modes.
Conclusion
HBV, HCV and HIV prevalences along the Maroni River were comparable to urban areas and remain concerning. Knowledge about viral hepatitis was low. Achieving viral hepatitis elimination goals requires awareness campaigns and test-and-treat strategies tailored to hard-to-serve populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- CIC Inserm 1424, Centre Hospitalier Universitaire de Guyane, Cayenne, French Guiana.
- Inserm UA 17 Santé des Populations en Amazonie, Cayenne, French Guiana.
- Foundation for Scientific Research Suriname (SWOS), Paramaribo, Suriname.
- Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Service de Maladies Infectieuses et Tropicales, CHU de la Réunion, St Denis, La Réunion.
- Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Antilles University, Montpellier University Hospital, Montpellier, France.
ORCID-Profile: Roxane Schaub, Mathieu Nacher
Förderung
- European Regional Development Fund
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
Zitieren
APA
Schaub, R., MacDonald-Ottevanger, M. S., Hoang, S., Pisoni, A., Bolloré, K., Biche, B., Neus, A., Bisnajak, R., Schinkel, J., Blanc, J., Grunberg, A., Naldjinan, R., Lucarelli, A., Rousseau, C., Michaud, C., Gaillet, M., Harkisoen, S., Gordien, E., Prins, M., …, & Vreden, S. (2026). A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname. PLOS One. https://doi.org/10.1371/journal.pone.0344187
Vancouver
Schaub R, MacDonald-Ottevanger MS, Hoang S, Pisoni A, Bolloré K, Biche B, et al. A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname. PLOS One. 2026. doi:10.1371/journal.pone.0344187
BibTeX
@article{Schaub2026,
author = {Schaub, Roxane and MacDonald-Ottevanger, M Sigrid and Hoang, Stella and Pisoni, Amandine and Bolloré, Karine and Biche, Barbara and Neus, Anfernee and Bisnajak, Rikesh and Schinkel, Janke and Blanc, Julie and Grunberg, Antoon and Naldjinan, Richard and Lucarelli, Aude and Rousseau, Cyril and Michaud, Céline and Gaillet, Melanie and Harkisoen, Soeradj and Gordien, Emmanuel and Prins, Maria and Tuaillon, Edouard and Nacher, Mathieu and Vreden, Stephen},
title = {A cross-border seroprevalence study on HBV, HCV, HDV and HIV in remote Amazonian communities on the border between French Guiana and Suriname},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0344187}
}
EUVIMED